Avinger Announces Pantheris SV Limited Launch and Successful Treatment of First Patients in the United States
July 29, 2019 08:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,...
Avinger to Effect One-for-Ten Reverse Stock Split
June 21, 2019 16:05 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., June 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for...
Avinger Provides First Quarter 2019 Shareholder Update
May 08, 2019 16:01 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based...
Avinger Receives FDA Clearance of Pantheris SV Device
April 10, 2019 08:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with...
Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update
March 06, 2019 16:05 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,...
Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device
December 13, 2018 07:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that...